Landscapes / Companies
Elpiscience Biopharma, Ltd. not checked
FollowEvery new trial, moved date and filing, and a Monday email
Furthest along
2 in Phase 2
Drugs
2
in active trials · 5 in all
Trials
0 active
6 since 2021
Drugs2
| Drug | How it works | Partner | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
— |
Inhibrx Biosciences · Elpiscience Biopharma |
Phase 2 | 28 Feb 2027Phase 2 trial completes | ||
| Next date | 28 Feb 2027 · Phase 2 trial completes | ||||
| Also tested for | Non-Small Cell Lung Cancer | ||||
| Open drug page | |||||
— |
Elpiscience (Suzhou) Biopharma |
Phase 2 | Jan 2028Phase 2 trial completes | ||
| Next date | Jan 2028 · Phase 2 trial completes | ||||
| Also tested for | Solid Tumor, Locally Advanced Solid Tumor and 2 more | ||||
| Open drug page | |||||
About
- SEC filings
- None: it does not file with the US SEC
- Sources
- ClinicalTrials.gov updated 19 Nov 2026 Industry-sponsored drug trials since 2021